ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 267713 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 267713; 2) Community: the network communities that were significantly associated with the response to NSC 267713; 3) Molecule: the relationships between components within communities and NSC 267713; 4) MDR: the compounds that were significantly associated with the NSC 267713.

NSC Compound Enrichment Correlation
NSC 617823 4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride 0.0352383000003051 0.14215167
NSC 745813 Null 0.0352383000003051 0.13536963
NSC 268993 Deferoxamine hydrochloride 0.0352383000003056 0.27186907
NSC 379651 Null 0.0352383000003056 -0.14606498
NSC 4320 .beta.-k-Strophanthin 0.0352383000003056 0.86841713
NSC 649677 Null 0.0352383000003056 0.23433356
NSC 661748 [6,6'-Bibenzo[6,7]cyclohepta[1,2,3-cd]benzofuran]-4,4',8,8', 10,10'-hexol, 1,1',6,6',7,7',11b,11'b-octahydro-1,1',7,7'- tetrakis(4-hydroxyphenyl)-, [1.alpha.,6.beta.(1'R*,6'S*,7'R*),7.alpha]- 0.0352383000003056 -0.11181574
NSC 664558 Null 0.0352383000003056 0.14622294
NSC 67239 as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-, triacetate 0.0352383000003056 0.13146511
NSC 674454 (Z)-3-iodo-1,2-diphenyl-2-propen-1-one 0.0352383000003056 -0.10405426
Total:49  Current:33    [First] [Prev] [Next] [Last]